Top compounds associated with response to PYURF


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 9e-06
mRNA ruxolitinib CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA XMD14-99 GDSC1000 pan-cancer AAC 0.13 8e-05
mRNA TG-101348 GDSC1000 pan-cancer AAC 0.11 0.0001
mRNA PD-0325901 GDSC1000 pan-cancer AAC 0.12 0.0001
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC 0.12 0.0004
mRNA IPA-3 GDSC1000 pan-cancer AAC -0.11 0.0005
mRNA procarbazine CTRPv2 pan-cancer AAC -0.14 0.0005
mRNA RDEA119 GDSC1000 pan-cancer AAC 0.11 0.0005
Download CSV